DE202023100017U1 - Novel drug for the prevention and treatment of bacterial mixed infections in freshwater fish - Google Patents
Novel drug for the prevention and treatment of bacterial mixed infections in freshwater fish Download PDFInfo
- Publication number
- DE202023100017U1 DE202023100017U1 DE202023100017.7U DE202023100017U DE202023100017U1 DE 202023100017 U1 DE202023100017 U1 DE 202023100017U1 DE 202023100017 U DE202023100017 U DE 202023100017U DE 202023100017 U1 DE202023100017 U1 DE 202023100017U1
- Authority
- DE
- Germany
- Prior art keywords
- medicinal composition
- parts
- freshwater fish
- fish
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 58
- 239000013505 freshwater Substances 0.000 title claims abstract description 48
- 230000002265 prevention Effects 0.000 title claims description 19
- 239000003814 drug Substances 0.000 title description 36
- 230000001580 bacterial effect Effects 0.000 title description 12
- 229940079593 drug Drugs 0.000 title description 6
- 208000003322 Coinfection Diseases 0.000 title description 4
- 239000000203 mixture Substances 0.000 claims abstract description 106
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- 208000035143 Bacterial infection Diseases 0.000 claims abstract description 11
- 208000022362 bacterial infectious disease Diseases 0.000 claims abstract description 11
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 9
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 9
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 6
- 238000000855 fermentation Methods 0.000 claims abstract description 6
- 230000004151 fermentation Effects 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000013500 Melia azadirachta Nutrition 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 7
- 235000013717 Houttuynia Nutrition 0.000 claims description 3
- 240000000691 Houttuynia cordata Species 0.000 claims description 3
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 3
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 3
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims description 2
- 235000008397 ginger Nutrition 0.000 claims description 2
- 244000237986 Melia azadirachta Species 0.000 claims 1
- 240000005343 Azadirachta indica Species 0.000 abstract description 4
- 235000019688 fish Nutrition 0.000 description 62
- 238000002360 preparation method Methods 0.000 description 21
- 238000000034 method Methods 0.000 description 12
- 241000411851 herbal medicine Species 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 10
- 239000011246 composite particle Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000002994 raw material Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000028774 intestinal disease Diseases 0.000 description 6
- 235000012343 cottonseed oil Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- 239000003674 animal food additive Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000596569 Encephalitozoon intestinalis Species 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- 206010040047 Sepsis Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- 241000205585 Aquilegia canadensis Species 0.000 description 2
- 235000006226 Areca catechu Nutrition 0.000 description 2
- 244000080767 Areca catechu Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 235000019733 Fish meal Nutrition 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 235000019779 Rapeseed Meal Nutrition 0.000 description 2
- 240000004980 Rheum officinale Species 0.000 description 2
- 235000008081 Rheum officinale Nutrition 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 239000006052 feed supplement Substances 0.000 description 2
- 239000004467 fishmeal Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000010440 gypsum Substances 0.000 description 2
- 229910052602 gypsum Inorganic materials 0.000 description 2
- 230000002434 immunopotentiative effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000004456 rapeseed meal Substances 0.000 description 2
- 208000013223 septicemia Diseases 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 1
- 239000004229 Alkannin Substances 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 241001127714 Amomum Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241001407408 Berberis fortunei Species 0.000 description 1
- 241000394759 Blumea megacephala Species 0.000 description 1
- 241000253115 Carpesium Species 0.000 description 1
- 241001355283 Cayratia Species 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 241000252099 Conger myriaster Species 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000196133 Dryopteris Species 0.000 description 1
- 244000148064 Enicostema verticillatum Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000221079 Euphorbia <genus> Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000287826 Gallus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- XJMPAUZQVRGFRE-SCHFUKFYSA-N Gardenoside Natural products O=C(OC)C=1[C@H]2[C@H]([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@@](O)(CO)C=C2 XJMPAUZQVRGFRE-SCHFUKFYSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 241000252498 Ictalurus punctatus Species 0.000 description 1
- 241000408747 Lepomis gibbosus Species 0.000 description 1
- 241001417534 Lutjanidae Species 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027626 Milia Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000009444 Nelumbinis Semen Substances 0.000 description 1
- 240000001659 Oldenlandia diffusa Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000157468 Reinhardtius hippoglossoides Species 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001482311 Trionychidae Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 206010047400 Vibrio infections Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 1
- 235000019232 alkannin Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001309 inhibitory effect on influenza Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000009318 large scale farming Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000009472 lonicerae flos Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- XJMPAUZQVRGFRE-AYDWLWLASA-N methyl (1s,4as,7s,7as)-7-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@](C=C2)(O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJMPAUZQVRGFRE-AYDWLWLASA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000150 monocalcium phosphate Inorganic materials 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000020236 pumpkin seed Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000009910 sargent gloryvine Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Farming Of Fish And Shellfish (AREA)
Abstract
Neuartige medizinische Zusammensetzung zur Vorbeugung und Behandlung einer bakteriellen Mischinfektion von Süßwasserfischen, wobei die neuartige medizinische Zusammensetzung verwendet wird, um das Wachstum der gezüchteten Fische zu fördern, wobei die medizinische Zusammensetzung durch Zugabe von Wasser zu der medizinischen Zusammensetzung, Beimpfen einer zusammengesetzten Kappa-Bohne und Fermentieren in einem Fermentationsbehälter hergestellt wird, um die fermentierte medizinische Zusammensetzung zu erhalten; wobei die medizinische Zusammensetzung dadurch gekennzeichnet ist, dass die medizinische Zusammensetzung die folgenden Komponenten in Gewichtsteilen umfasst,
45 % bis 55 % Coptis chinensis, bezogen auf das Gesamtgewicht der medizinischen Zusammensetzung;
24 % bis 46 % Kappa-Bohne, bezogen auf das Gesamtgewicht der medizinischen Zusammensetzung;
15 % bis 25 % Blattmischung von Azadirachta indica, bezogen auf das Gesamtgewicht der medizinischen Zusammensetzung; und
10 % bis 30 % eines Mediums des Gesamtgewichts der medizinischen Zusammensetzung.Novel medicinal composition for preventing and treating mixed bacterial infection of freshwater fish, the novel medicinal composition being used to promote the growth of farmed fish, the medicinal composition being prepared by adding water to the medicinal composition, inoculating a compound kappa bean and fermenting in a fermentation tank to obtain the fermented medicinal composition; wherein the medicinal composition is characterized in that the medicinal composition comprises the following components in parts by weight,
45% to 55% Coptis chinensis based on the total weight of the medicinal composition;
24% to 46% kappa bean based on the total weight of the medicinal composition;
15% to 25% Azadirachta indica leaf blend based on the total weight of the medicinal composition; and
10% to 30% of a medium of the total weight of the medicinal composition.
Description
BEREICH DER ERFINDUNGFIELD OF THE INVENTION
Die vorliegende Erfindung bezieht sich auf das Gebiet der medizinischen Zusammensetzung für Süßwasserfische.The present invention relates to the field of medicinal compositions for freshwater fish.
Die vorliegende Erfindung bezieht sich auf das Gebiet der Zusammensetzung zur Behandlung von bakteriellen Mischinfektionen bei Süßwasserfischen.The present invention relates to the field of compositions for the treatment of mixed bacterial infections in freshwater fish.
Insbesondere bezieht sich die vorliegende Erfindung auf eine neue medizinische Zusammensetzung zur Vorbeugung und Behandlung von bakteriellen Mischinfektionen bei Süßwasserfischen.More particularly, the present invention relates to a novel medicinal composition for the prevention and treatment of mixed bacterial infections in freshwater fish.
HINTERGRUND DER ERFINDUNGBACKGROUND OF THE INVENTION
Bei dem im Abschnitt „Hintergrund“ behandelten Gegenstand sollte nicht davon ausgegangen werden, dass er allein aufgrund seiner Erwähnung im Abschnitt „Hintergrund“ zum Stand der Technik gehört. Ebenso sollte nicht davon ausgegangen werden, dass ein im Hintergrundabschnitt erwähntes oder mit dem Gegenstand des Hintergrundabschnitts verbundenes Problem bereits im Stand der Technik erkannt worden ist. Der Gegenstand des Hintergrundabschnitts stellt lediglich verschiedene Ansätze dar, die für sich genommen ebenfalls Erfindungen sein können.The subject matter discussed in the background section should not be assumed to constitute prior art merely by virtue of its mention in the background section. Likewise, it should not be assumed that any problem mentioned in the background section or associated with the subject matter of the background section has already been recognized in the prior art. The subject matter of the background section merely presents various approaches, which in themselves may also be inventions.
Wie in der vorliegenden Beschreibung und in den folgenden Ansprüchen verwendet, schließt die Bedeutung von „ein“, „eine“ und „die“ den Plural ein, sofern der Kontext nicht eindeutig etwas anderes vorschreibt. Wie in der vorliegenden Beschreibung verwendet, schließt die Bedeutung von „in“ auch „in“ und „am“ ein, sofern der Kontext nicht eindeutig etwas anderes vorschreibt.As used in the present specification and the following claims, the meaning of "a", "an" and "the" includes the plural unless the context clearly dictates otherwise. As used in the present specification, the meaning of "in" also includes "in" and "am" unless the context clearly dictates otherwise.
Die Aufzählung von Wertebereichen dient lediglich als Kurzbezeichnung für jeden einzelnen Wert, der in den Bereich fällt. Sofern hier nicht anders angegeben, wird jeder einzelne Wert in die Spezifikation aufgenommen, als ob er hier einzeln aufgeführt wäre.The enumeration of value ranges serves only as a short name for each individual value that falls within the range. Unless otherwise noted here, each individual value is included in the specification as if it were individually listed here.
Die Verwendung von Beispielen oder beispielhaften Formulierungen (z. B. „wie“) in Bezug auf bestimmte Ausführungsformen dient lediglich der besseren Veranschaulichung der Erfindung und stellt keine Einschränkung des Umfangs der ansonsten beanspruchten Erfindung dar. Keine Formulierung in der Beschreibung ist als Hinweis auf ein nicht beanspruchtes Element zu verstehen, das für die Ausübung der Erfindung wesentlich ist.The use of examples or exemplary language (e.g., "such as") with respect to particular embodiments is intended solely to better illustrate the invention and should not be construed as limiting the scope of the otherwise claimed invention. No language in the specification is intended as an indication of a unclaimed element essential to the practice of the invention.
Die in diesem Abschnitt „Hintergrund“ offengelegten Informationen dienen lediglich dem besseren Verständnis des Hintergrunds der Erfindung und können daher Informationen enthalten, die nicht zum Stand der Technik gehören und die einem Fachmann in diesem Land bereits bekannt sind.The information disclosed in this Background section is only for enhancement of understanding of the background of the invention and therefore it may contain information that is not pertinent to state of the art and which are already known to a person skilled in the art in this country.
ZUSAMMENFASSUNGSUMMARY
Bevor die vorliegenden Systeme und Methoden beschrieben werden, sei darauf hingewiesen, dass diese Anwendung nicht auf die beschriebenen Systeme und Methoden beschränkt ist, da es mehrere mögliche Ausführungsformen geben kann, die in der vorliegenden Offenlegung nicht ausdrücklich dargestellt sind. Es ist auch zu verstehen, dass die in der Beschreibung verwendete Terminologie nur zur Beschreibung der besonderen Versionen oder Ausführungsformen dient und nicht dazu gedacht ist, den Umfang der vorliegenden Anwendung zu begrenzen.Before describing the present systems and methods, it should be noted that this application is not limited to the systems and methods described, as there may be several possible embodiments that are not expressly illustrated in the present disclosure. It is also to be understood that the terminology used in the specification is for the purpose of describing particular versions or embodiments only and is not intended to limit the scope of the present application.
Die vorliegende Erfindung heilt und löst vor allem die technischen Probleme, die im Stand der Technik bestehen. Als Reaktion auf diese Probleme, die vorliegende Erfindung offenbart Novel medizinische Zusammensetzung für die Prävention und Behandlung von bakteriellen Mix-Infektion von Süßwasserfischen.Above all, the present invention heals and solves the technical problems that exist in the prior art. In response to these problems, the present invention discloses novel medicinal composition for the prevention and treatment of bacterial mix infection of freshwater fish.
Ein Aspekt der vorliegenden Erfindung besteht darin, eine neuartige medizinische Zusammensetzung zur Vorbeugung und Behandlung einer bakteriellen Mischinfektion von Süßwasserfischen zu präsentieren, wobei die neuartige medizinische Zusammensetzung verwendet wird, um das Wachstum der gezüchteten Fische zu fördern, wobei die medizinische Zusammensetzung unter Verwendung der Zugabe von Wasser in die medizinische Zusammensetzung, des Beimpfens einer zusammengesetzten Kappa-Bohne und des Fermentierens in einem Fermentationsbehälter hergestellt wird, um die fermentierte medizinische Zusammensetzung zu erhalten; wobei die medizinische Zusammensetzung dadurch gekennzeichnet ist, dass die medizinische Zusammensetzung die folgenden Komponenten in Gewichtsteilen umfasst: 45% bis 55% Coptis chinensis des Gesamtgewichts der medizinischen Zusammensetzung; 24% bis 46% Kappa-Bohne des Gesamtgewichts der medizinischen Zusammensetzung; 15% bis 25% Blattmischung von Azadirachta indica des Gesamtgewichts der medizinischen Zusammensetzung; und 10% bis 30% eines Mediums des Gesamtgewichts der medizinischen Zusammensetzung.One aspect of the present invention is to present a novel medicinal composition for preventing and treating a mixed bacterial infection of freshwater fish, the novel medicinal composition being used to promote the growth of the farmed fish, the medicinal composition using the addition of water into the medicinal composition, inoculating a compound kappa bean and fermenting in a fermentation tank to obtain the fermented medicinal composition; the medicinal composition being characterized in that the medicinal composition comprises the following components in parts by weight: 45% to 55% Coptis chinensis of the total weight of the medicinal composition; 24% to 46% kappa bean of the total weight of the medicinal composition; 15% to 25% Azadirachta indica leaf mix of the total weight of the medicinal composition; and 10% to 30% of a medium by the total weight of the medicinal composition.
DETAILLIERTE BESCHREIBUNGDETAILED DESCRIPTION
Die vorliegende Erfindung bezieht sich auf eine neue medizinische Zusammensetzung zur Vorbeugung und Behandlung von bakteriellen Mischinfektionen bei Süßwasserfischen.The present invention relates to a new medicinal composition for the prevention and treatment of mixed bacterial infections in freshwater fish.
Obwohl die vorliegende Offenbarung mit dem Zweck der Novel medizinische Zusammensetzung zur Vorbeugung und Behandlung von bakteriellen Mix-Infektion von Süßwasserfischen beschrieben worden ist, sollte geschätzt werden, dass dies nur getan wurde, um die Erfindung in einer beispielhaften Weise zu veranschaulichen und jeden anderen Zweck oder Funktion zu markieren, für die erklärte Strukturen oder Konfigurationen verwendet werden könnten und ist innerhalb des Anwendungsbereichs der vorliegenden Offenbarung abgedeckt.Although the present disclosure has been described with the purpose of novel medicinal composition for the prevention and treatment of bacterial mix infection of freshwater fish, it should be appreciated that this was done only to illustrate the invention in an exemplary manner and for any other purpose or marking function for which stated structures or configurations could be used and is covered within the scope of the present disclosure.
Das neuartige Arzneimittel zur Vorbeugung und Behandlung von bakteriellen Mischinfektionen bei Süßwasserfischen wird in der vorliegenden Offenlegungsschrift offengelegt.The novel drug for the prevention and treatment of bacterial mixed infections in freshwater fish is disclosed in the present patent application.
Die neuartige medizinische Zusammensetzung wird zur Förderung des Wachstums von Zuchtfischen verwendet.The novel medicinal composition is used to promote the growth of farmed fish.
Die medizinische Zusammensetzung wird durch Zugabe von Wasser in die medizinische Zusammensetzung, Impfen einer zusammengesetzten Kappa-Bohne und Fermentieren in einem Fermentationsbehälter hergestellt, um die fermentierte medizinische Zusammensetzung zu erhalten.The medicinal composition is prepared by adding water into the medicinal composition, seeding a compound kappa bean and fermenting in a fermentation tank to obtain the fermented medicinal composition.
Medizinische Zusammensetzung, dadurch gekennzeichnet, dass die medizinische Zusammensetzung die folgenden Komponenten in Gewichtsteilen umfasst: Coptis chinensis, Kappa-Bohne, Blattmischung von Azadirachta indica und ein Medium.Medicinal composition characterized in that the medicinal composition comprises the following components in parts by weight: Coptis chinensis, kappa bean, leaf mixture of Azadirachta indica and a medium.
Die medizinische Zusammensetzung enthält 45 % bis 55 % Coptis chinensis, bezogen auf das Gesamtgewicht der medizinischen Zusammensetzung.The medicinal composition contains 45% to 55% Coptis chinensis based on the total weight of the medicinal composition.
Die medizinische Zusammensetzung enthält 24 bis 46 % Kappa-Bohnen, bezogen auf das Gesamtgewicht der medizinischen Zusammensetzung.The medicinal composition contains 24 to 46% kappa beans based on the total weight of the medicinal composition.
Die medizinische Zusammensetzung enthält 15 bis 25 % Blattmischung von Azadirachta indica, bezogen auf das Gesamtgewicht der medizinischen Zusammensetzung.The medicinal composition contains 15 to 25% leaf mixture of Azadirachta indica based on the total weight of the medicinal composition.
Die medizinische Zusammensetzung enthält 10 bis 30 % eines Mediums, bezogen auf das Gesamtgewicht der medizinischen Zusammensetzung.The medicinal composition contains 10 to 30% of a medium based on the total weight of the medicinal composition.
Die neue medizinische Zusammensetzung enthält außerdem Ingwerpulver.The new medicinal composition also includes ginger powder.
Die neue medizinische Zusammensetzung enthält außerdem Pulver von Cordate Houttuynia.The new medicinal composition also includes Cordate Houttuynia powder.
Die neue medizinische Zusammensetzung enthält außerdem Montmorillonitpulver.The new medicinal composition also contains montmorillonite powder.
Obwohl Ausführungsformen der Erfindung in einer für strukturelle Merkmale und/oder Methoden spezifischen Sprache beschrieben wurden, sind die beigefügten Ansprüche nicht notwendigerweise auf die beschriebenen spezifischen Merkmale oder Methoden beschränkt. Vielmehr werden die spezifischen Merkmale und Methoden als Beispiele für Ausführungsformen der Erfindung offenbart.Although embodiments of the invention have been described in language specific to structural features and/or methods, the appended claims are not necessarily limited to the specific features or methods described. Rather, the specific features and methods are disclosed as examples of embodiments of the invention.
ZITATE ENTHALTEN IN DER BESCHREIBUNGQUOTES INCLUDED IN DESCRIPTION
Diese Liste der vom Anmelder aufgeführten Dokumente wurde automatisiert erzeugt und ist ausschließlich zur besseren Information des Lesers aufgenommen. Die Liste ist nicht Bestandteil der deutschen Patent- bzw. Gebrauchsmusteranmeldung. Das DPMA übernimmt keinerlei Haftung für etwaige Fehler oder Auslassungen.This list of documents cited by the applicant was generated automatically and is included solely for the better information of the reader. The list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions.
Zitierte PatentliteraturPatent Literature Cited
- CN 109224024 [0005]CN109224024 [0005]
- CN 112043760 [0006]CN112043760 [0006]
- CN 103656020 [0007]CN103656020 [0007]
- CN 114681545 [0008]CN 114681545 [0008]
- CN 103768205 [0009]CN 103768205 [0009]
- CN 1218628 [0010]CN 1218628 [0010]
- CN 103656401 [0011]CN103656401 [0011]
- CN 106692630 [0012]CN106692630 [0012]
- CN 106551176 [0013]CN 106551176 [0013]
- JP 1999169099 [0014]JP 1999169099 [0014]
- CN 1065511731 [0015]CN 1065511731 [0015]
- CN 109125643 [0016]CN 109125643 [0016]
- CN 109247455 [0017]CN 109247455 [0017]
- CN 113693160 [0018]CN 113693160 [0018]
- CN 104664160 [0019]CN 104664160 [0019]
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE202023100017.7U DE202023100017U1 (en) | 2023-01-03 | 2023-01-03 | Novel drug for the prevention and treatment of bacterial mixed infections in freshwater fish |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE202023100017.7U DE202023100017U1 (en) | 2023-01-03 | 2023-01-03 | Novel drug for the prevention and treatment of bacterial mixed infections in freshwater fish |
Publications (1)
Publication Number | Publication Date |
---|---|
DE202023100017U1 true DE202023100017U1 (en) | 2023-02-17 |
Family
ID=85477644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE202023100017.7U Active DE202023100017U1 (en) | 2023-01-03 | 2023-01-03 | Novel drug for the prevention and treatment of bacterial mixed infections in freshwater fish |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE202023100017U1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116617238A (en) * | 2023-05-29 | 2023-08-22 | 中国科学院水生生物研究所 | Application of Chinese herbal medicine saffron glycoside I in fish antiviral |
CN117204380A (en) * | 2023-09-06 | 2023-12-12 | 渤海水产股份有限公司 | Anti-stress breeding method suitable for saline-alkali soil cultivation |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1218628A (en) | 1997-11-28 | 1999-06-09 | 金东秀 | Crude drug composition for feed addition for improving cultivation of fish grow |
JPH11169099A (en) | 1997-11-27 | 1999-06-29 | Dong Soo Kim | Crude medicine composition or adding to feed for farmed fishes |
CN103656401A (en) | 2012-09-24 | 2014-03-26 | 天津瑞贝特科技发展有限公司 | Traditional Chinese medicine composition for preventing and treating bacterial gill-rot disease of freshwater fish and preparation method thereof |
CN103656020A (en) | 2012-09-24 | 2014-03-26 | 天津瑞贝特科技发展有限公司 | Traditional Chinese medicine composition for treating encephalitozoon intestinalis of freshwater fish and preparation method thereof |
CN103768205A (en) | 2012-10-24 | 2014-05-07 | 天津中敖生物科技有限公司 | Traditional Chinese medicine composition for treating freshwater fish bacterial liver-gall syndrome and preparation method of traditional Chinese medicine composition |
CN104664160A (en) | 2015-02-14 | 2015-06-03 | 河南牧业经济学院 | Composite particle preparation having physiological functions for freshwater fishes and production method of composite particle preparation |
CN106511731A (en) | 2015-09-10 | 2017-03-22 | 谢咸玉 | Cold Chinese traditional medicine |
CN106551176A (en) | 2016-10-31 | 2017-04-05 | 通化师范学院 | A kind of Chinese herbal feed additive compositionss and application thereof |
CN106692630A (en) | 2015-11-13 | 2017-05-24 | 鼎正动物药业(天津)有限公司 | Compound traditional Chinese medicine for preventing and treating stigmatosis of freshwater fish |
CN109125643A (en) | 2018-08-17 | 2019-01-04 | 北海市绿滴生物科技有限公司 | A kind of fermented tcm and preparation method thereof preventing and treating aquatic products intestines problem |
CN109224024A (en) | 2018-11-27 | 2019-01-18 | 西南民族大学 | For preventing and treating the pharmaceutical composition and its application method of fresh-water fishes bacteria mixed infection |
CN109247455A (en) | 2018-08-31 | 2019-01-22 | 河南华牧生物科技有限公司 | Fresh-water fishes liver protecting Immune-enhancing effect granule and preparation method thereof |
CN112043760A (en) | 2020-10-12 | 2020-12-08 | 于剑 | Traditional Chinese medicine composition for treating gill rot disease of freshwater fish and preparation method thereof |
CN113693160A (en) | 2021-08-30 | 2021-11-26 | 中国水产科学研究院淡水渔业研究中心 | Functional feed and preparation method thereof |
CN114681545A (en) | 2020-12-31 | 2022-07-01 | 鼎正新兴生物技术(天津)有限公司 | Chinese herbal medicine composition for treating fish septicemia and preparation method thereof |
-
2023
- 2023-01-03 DE DE202023100017.7U patent/DE202023100017U1/en active Active
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11169099A (en) | 1997-11-27 | 1999-06-29 | Dong Soo Kim | Crude medicine composition or adding to feed for farmed fishes |
CN1218628A (en) | 1997-11-28 | 1999-06-09 | 金东秀 | Crude drug composition for feed addition for improving cultivation of fish grow |
CN103656401A (en) | 2012-09-24 | 2014-03-26 | 天津瑞贝特科技发展有限公司 | Traditional Chinese medicine composition for preventing and treating bacterial gill-rot disease of freshwater fish and preparation method thereof |
CN103656020A (en) | 2012-09-24 | 2014-03-26 | 天津瑞贝特科技发展有限公司 | Traditional Chinese medicine composition for treating encephalitozoon intestinalis of freshwater fish and preparation method thereof |
CN103768205A (en) | 2012-10-24 | 2014-05-07 | 天津中敖生物科技有限公司 | Traditional Chinese medicine composition for treating freshwater fish bacterial liver-gall syndrome and preparation method of traditional Chinese medicine composition |
CN104664160A (en) | 2015-02-14 | 2015-06-03 | 河南牧业经济学院 | Composite particle preparation having physiological functions for freshwater fishes and production method of composite particle preparation |
CN106511731A (en) | 2015-09-10 | 2017-03-22 | 谢咸玉 | Cold Chinese traditional medicine |
CN106692630A (en) | 2015-11-13 | 2017-05-24 | 鼎正动物药业(天津)有限公司 | Compound traditional Chinese medicine for preventing and treating stigmatosis of freshwater fish |
CN106551176A (en) | 2016-10-31 | 2017-04-05 | 通化师范学院 | A kind of Chinese herbal feed additive compositionss and application thereof |
CN109125643A (en) | 2018-08-17 | 2019-01-04 | 北海市绿滴生物科技有限公司 | A kind of fermented tcm and preparation method thereof preventing and treating aquatic products intestines problem |
CN109247455A (en) | 2018-08-31 | 2019-01-22 | 河南华牧生物科技有限公司 | Fresh-water fishes liver protecting Immune-enhancing effect granule and preparation method thereof |
CN109224024A (en) | 2018-11-27 | 2019-01-18 | 西南民族大学 | For preventing and treating the pharmaceutical composition and its application method of fresh-water fishes bacteria mixed infection |
CN112043760A (en) | 2020-10-12 | 2020-12-08 | 于剑 | Traditional Chinese medicine composition for treating gill rot disease of freshwater fish and preparation method thereof |
CN114681545A (en) | 2020-12-31 | 2022-07-01 | 鼎正新兴生物技术(天津)有限公司 | Chinese herbal medicine composition for treating fish septicemia and preparation method thereof |
CN113693160A (en) | 2021-08-30 | 2021-11-26 | 中国水产科学研究院淡水渔业研究中心 | Functional feed and preparation method thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116617238A (en) * | 2023-05-29 | 2023-08-22 | 中国科学院水生生物研究所 | Application of Chinese herbal medicine saffron glycoside I in fish antiviral |
CN117204380A (en) * | 2023-09-06 | 2023-12-12 | 渤海水产股份有限公司 | Anti-stress breeding method suitable for saline-alkali soil cultivation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105341415B (en) | A kind of Chinese medicinal herb pig feed additive and preparation method thereof | |
CN102845638B (en) | Duck feed capable of preventing and treating avian influenza and Chinese herbal additive used therein | |
CN101698024B (en) | Traditional Chinese medicine for treating respiratory diseases and promoting growth for swine and preparation method thereof | |
DE202023100017U1 (en) | Novel drug for the prevention and treatment of bacterial mixed infections in freshwater fish | |
CN102940155B (en) | Duckling feed for cherry valley duck and preparation method thereof | |
CN105230568A (en) | Breeding method of high-immunity and high-quality live pigs | |
CN105287790B (en) | A kind of fevervine extract and its application | |
CN105767587A (en) | Traditional Chinese medicine microecological preparation for improving laying hen performance and preparation method of traditional Chinese medicine microecological preparation for improving laying hen performance | |
CN101785533B (en) | Nutrition regulator for pigs | |
CN106667915B (en) | It is a kind of for treating the scutelloside aluminium dry suspensoid agent of grice diarrhoea | |
CN106666099A (en) | Pig feed preventing and treating gastrointestinal diseases | |
CN105168807B (en) | The Chinese medicine composition and preparation method thereof for treating pig blue-ear disease | |
CN106109762A (en) | A kind of Chinese medicine preparation preventing and treating pig bacterial disease and preparation method thereof | |
CN105028925A (en) | Chinese herbal medicine feed nutrient for poultry | |
CN106135748A (en) | A kind of fowl Chinese herbal medicine microorganism composite feed additive | |
CN106039138A (en) | Lactic acid bacteria traditional Chinese medicine fermentation antiviral preparation for aquaculture | |
CN102078372A (en) | Chinese herbal medicine composition for enhancing disease resistance of broiler chickens | |
CN103892048A (en) | Feed additive with functions of soothing nerves, enhancing immunity and promoting growth for piglet and preparation method and application of additive | |
CN103656366B (en) | A kind ofly treat Chinese medicine of diarrhea of weaned piglets in winter and preparation method thereof | |
CN103393891B (en) | Antiviral compound traditional Chinese medicine for animals, and preparation method and use thereof | |
CN109432287B (en) | Traditional Chinese medicine oral liquid for preventing and treating excessive heat syndrome of poultry qi system and preparation method thereof | |
CN102266438B (en) | Antiviral agent for freshwater fishes | |
CN101879233A (en) | Chinese medicinal composition for treating viral diseases of poultry and preparation method thereof | |
CN105901416A (en) | Feed for increasing survival rate of crabs | |
CN105166484A (en) | Chicken feed containing Chinese herbal medicine additives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R207 | Utility model specification | ||
R082 | Change of representative |
Representative=s name: LIPPERT STACHOW PATENTANWAELTE RECHTSANWAELTE , DE |